Literature DB >> 3563263

[Arterial embolization in the treatment of hemobilia].

A J Ganc.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3563263

Source DB:  PubMed          Journal:  Rev Paul Med        ISSN： 0035-0362


× No keyword cloud information.
  13 in total

1.  Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer.

Authors:  Neelima Vidula; Christina Yau; Hope S Rugo
Journal:  Breast Cancer Res Treat       Date:  2021-04-28       Impact factor: 4.872

Review 2.  Industrializing engineered autologous T cells as medicines for solid tumours.

Authors:  Cedrik M Britten; Aiman Shalabi; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2021-04-08       Impact factor: 84.694

Review 3.  The Use of Targeted Agents in the Treatment of Gynecologic Cancers.

Authors:  Shaina F Bruce; Matthew A Powell
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

4.  In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.

Authors:  Daniel J Rubins; Xiangjun Meng; Paul McQuade; Michael Klimas; Krista Getty; Shu-An Lin; Brett M Connolly; Stacey S O'Malley; Hyking Haley; Mona Purcell; Liza Gantert; Marie Holahan; Joel Lindgren; Pär Eklund; Caroline Ekblad; Fredrik Y Frejd; Eric D Hostetler; Dinko E González Trotter; Jeffrey L Evelhoch
Journal:  Mol Imaging Biol       Date:  2020-10-23       Impact factor: 3.488

Review 5.  Microbiota in pancreatic health and disease: the next frontier in microbiome research.

Authors:  Ryan M Thomas; Christian Jobin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-06       Impact factor: 46.802

Review 6.  Phase I trials as valid therapeutic options for patients with cancer.

Authors:  Jacob J Adashek; Patricia M LoRusso; David S Hong; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2019-09-02       Impact factor: 66.675

Review 7.  Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.

Authors:  Pedro Iglesias; Juan Cristóbal Sánchez; Juan José Díez
Journal:  Pituitary       Date:  2021-03-24       Impact factor: 4.107

Review 8.  Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors.

Authors:  Maddalena Centanni; Dirk Jan A R Moes; Iñaki F Trocóniz; Joseph Ciccolini; J G Coen van Hasselt
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

9.  Immune checkpoint modulation enhances HIV-1 antibody induction.

Authors:  Todd Bradley; Masayuki Kuraoka; Chen-Hao Yeh; Ming Tian; Huan Chen; Derek W Cain; Xuejun Chen; Cheng Cheng; Ali H Ellebedy; Robert Parks; Maggie Barr; Laura L Sutherland; Richard M Scearce; Cindy M Bowman; Hilary Bouton-Verville; Sampa Santra; Kevin Wiehe; Mark G Lewis; Ane Ogbe; Persephone Borrow; David Montefiori; Mattia Bonsignori; M Anthony Moody; Laurent Verkoczy; Kevin O Saunders; Rafi Ahmed; John R Mascola; Garnett Kelsoe; Frederick W Alt; Barton F Haynes
Journal:  Nat Commun       Date:  2020-02-19       Impact factor: 17.694

10.  Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.

Authors:  Xiaoqiang Gu; Qiqi Zhang; Xueying Wu; Yue Fan; Jianxin Qian
Journal:  World J Surg Oncol       Date:  2021-04-12       Impact factor: 2.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.